耕莘护理专科学校.ppt

  1. 1、本文档共178页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
耕莘护理专科学校

Clinical Trial 報告者:郭梅珍、江倫志、王美華 指導教授:周桂如教授 報告日期:98.12.08 大綱 一、Definition ? 二、Design Principles 1.Sample size and power estimates 2.Randomization 3.Treatment masking 4.Design factors ?三、Stages Definition Is a planned experiment designed to assess the efficacy of a treatment by comparing the outcomes in a group of patients treated with the test treatment with those observed in a comparable group of patients receiving a control treatment,where patient in both groups are enrolled,treated,and followed over the same time period. Sample size and power estimate The number of subjects in a clinical trial should be large enough to provide a reliable answer to the questions addressed,but should also be the minimum necessary to achieve this aim Statistic considerations Practice considerations Literature review Power Effect size variable scale precision Variability Sample size compliance Sample size calculation 最常使用-Single outcome, dichotomous response 需要四項資訊 P1 –對照組成功的比例 P2 –治療組成功的比例 α–type I error,通常設為0.05 1-β–能正確地辨明兩組之間差異的統計檢力(power) 各組需要的個案數可由下列公式計算 舉例來說,如果假設p1=90%、p2=95%、α= 0.05、β= 0.1 quantitative measurements,如血壓值等? 需要四項資訊? μ1 –對照組的平均值、及σ(SD)? δ(μ2 -μ1) –預期治療組比上對照組的差異 α 1-β ?各組需要的個案數可由下列公式計算 Sample Size Determination Information Required Study objectives Test for equivalence Test for non-inferiority Test for superiority (clinically/statistically) Study design Parallel or crossover Group sequential design Other designs Primary study endpoint(s) Continuous or discrete Multiple study endpoints Sample Size Determination Information Required Clinically meaningful difference Clinically important difference Non-inferiority/superiority margin Equivalence/similarity limit Significance level 1% or 5% Desired power 80% or 90% Other information, e.g., Stratification? 1:1 ratio or 2:1 ratio? Log-transformation? Major principles in clinical trials Minimizing bias Maximizing precision Identify possible sources of bias. Are the trial results robust relative to these bias? Rando

您可能关注的文档

文档评论(0)

wujianz + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档